|
|
|
|
Vol. 62, Issue 6, 1393-1399, December 2002
Clinical Pharmacokinetics, Division of Clinical Pharmacy,
Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical
Sciences, Kyushu University, Fukuoka, Japan
One of the most indispensable biological functions for all living
organisms is the circadian clock, which acts like a multifunctional timer to regulate the homeostatic system, including sleep and wakefulness, hormonal secretions, and various other bodily functions with a 24-h cycle. We reported previously that interferon (IFN) has the
ability to modulate the biological clock system at the genetic level.
In the present study, this mechanism was investigated further by
evaluating the effects of IFN-
on circadian output function.
Treatment of cultured hepatic cells (HepG2) with IFN-
significantly
decreased the protein levels of CLOCK and BMAL1, which are
positive regulators of circadian output rhythm, then their mRNA levels.
Aurintricarboxylic acid, a ligand inhibitor of IFN-
, dose
dependently inhibited the IFN-
-induced phosphorylation of the
signal transducer and activator of transcription 1 (STAT1) protein in
HepG2 cells, accompanied by the restoration of Clock and
Bmal1 mRNA levels. The continuous administration of IFN-
significantly decreased CLOCK and BMAL1 protein levels in the suprachiasmatic nucleus and liver of mice, thereby preventing oscillations in the expression of clock and clock-controlled output genes. These results reveal a possible pharmacological action by
IFN-
on the core circadian oscillation mechanism and indicate that
the disruptive effect of IFN-
on circadian output function is the
underlying cause of its adverse effects on 24-h rhythms in physiology
and behavior.
This article has been cited by other articles:
![]() |
Y. Kwak, G. B. Lundkvist, J. Brask, A. Davidson, M. Menaker, K. Kristensson, and G. D. Block Interferon-{gamma} Alters Electrical Activity and Clock Gene Expression in Suprachiasmatic Nucleus Neurons J Biol Rhythms, April 1, 2008; 23(2): 150 - 159. [Abstract] [PDF] |
||||
![]() |
M. Yoshida, S. Koyanagi, A. Matsuo, T. Fujioka, H. To, S. Higuchi, and S. Ohdo Glucocorticoid Hormone Regulates the Circadian Coordination of {micro}-Opioid Receptor Expression in Mouse Brainstem J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1119 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakagawa, S. Koyanagi, T. Takiguchi, Y. Kuramoto, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo 24-Hour Oscillation of Mouse Methionine Aminopeptidase2, a Regulator of Tumor Progression, Is Regulated by Clock Gene Proteins Cancer Res., November 15, 2004; 64(22): 8328 - 8333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, S. Ohdo, H. Takane, Y. Tomiyoshi, A. Matsuo, E. Yukawa, and S. Higuchi Chronopharmacology of Analgesic Effect and Its Tolerance Induced by Morphine in Mice J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||